However, the available data appears to indicate that met-DNA following NAC is a highly significant prognostic indicator for poor prognosis, as none of the patients that were positive for met-DNA attained pCR, and as many as 86% developed recurrence.
← all excerpts
Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis.
1
—
—